The Comparison of the Kidney Effects of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide 1 Agonist-Administered Concomitant with Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease

METHODS: We retrospectively constructed database of 763 Japanese patients with T2DM and CKD who received sSGLT2is for more than 1 year. Among these SGLT2i-treated patients, 338 were receiving concomitant DPP4i (DPP4i group), and 99 were receiving concomitant GLP1Ra (GLP1Ra group). The two groups wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Kazuo, Toyoda, Masao, Hatori, Nobuo, Sato, Kazuyoshi, Miyakawa, Masaaki, Tamura, Kouichi, Kanamori, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749372/
https://www.ncbi.nlm.nih.gov/pubmed/35028319
http://dx.doi.org/10.1155/2021/6573369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749372/
https://www.ncbi.nlm.nih.gov/pubmed/35028319
http://dx.doi.org/10.1155/2021/6573369

Ejemplares similares